nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ASCO 2022 update: (neo-)adjuvant treatment of colorectal cancer
|
Piringer, Gudrun |
|
|
15 |
Suppl 6 |
p. 264-268 |
artikel |
2 |
Cardiotoxicity—current recommendations of prevention and treatment
|
Bergler-Klein, Jutta |
|
|
15 |
Suppl 6 |
p. 67-71 |
artikel |
3 |
CAR T cells in multiple myeloma: Where we stand and where we might be going
|
Zojer, Niklas |
|
|
15 |
Suppl 6 |
p. 185-189 |
artikel |
4 |
Clinical characteristics and prognostic value of 1q21 gain detected by fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma
|
Xiao, Xiao |
|
|
15 |
Suppl 6 |
p. 90-93 |
artikel |
5 |
Endometrial cancer: news from ASCO
|
Petru, Edgar |
|
|
15 |
Suppl 6 |
p. 275-277 |
artikel |
6 |
Essential news and practice changing trials in oesophageal, gastroesophageal junction and gastric cancer in 2021
|
Reimann, Patrick |
|
|
15 |
Suppl 6 |
p. 238-242 |
artikel |
7 |
High mortality in patients with active malignancy and severe COVID-19
|
Udovica, Simon |
|
|
15 |
Suppl 6 |
p. 153-160 |
artikel |
8 |
Molecular profiling in colorectal cancer
|
Piringer, Gudrun |
|
|
15 |
Suppl 6 |
p. 206-210 |
artikel |
9 |
New targeted therapies in kidney cancer
|
Mayrhofer, Karl |
|
|
15 |
Suppl 6 |
p. 133-136 |
artikel |
10 |
Pharmacokinetic drug interactions of oral anticancer drugs
|
Gampenrieder Satory, Julia |
|
|
15 |
Suppl 6 |
p. 298-302 |
artikel |
11 |
Renal cell carcinoma—presentation highlights from the ESMO Congress 2021
|
Hutterer, Georg C. |
|
|
15 |
Suppl 6 |
p. 102-106 |
artikel |
12 |
Tracking mutation and drug-driven alterations of oncokinase conformations
|
Feichtner, Andreas |
|
|
15 |
Suppl 6 |
p. 137-142 |
artikel |